Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Convertible Debt (2022 - 2023)

Envoy Medical's Convertible Debt history spans 2 years, with the latest figure at $2.5 million for Q4 2023.

  • Quarterly results put Convertible Debt at $2.5 million for Q4 2023, down 92.51% from a year ago — trailing twelve months through Dec 2023 was $2.5 million (down 92.51% YoY), and the annual figure for FY2023 was $2.5 million, down 92.51%.
  • Convertible Debt for Q4 2023 was $2.5 million at Envoy Medical, down from $4.0 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $33.4 million in Q4 2022 to a low of $2.5 million in Q4 2023.